Bayer unit BlueRock wins FDA and EMA orphan drug designations for OpCT-001

BlueRock, a Bayer unit, received FDA orphan drug status for lemiretprocel (OpCT-001) in primary photoreceptor diseases, and the EMA also granted an orphan designation.